1832 Asset Management L.P. Astrazeneca PLC Transaction History
1832 Asset Management L.P.
- $51.1 Billion
- Q4 2024
A detailed history of 1832 Asset Management L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, 1832 Asset Management L.P. holds 25,696 shares of AZN stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,696
Previous 26,528
3.14%
Holding current value
$1.91 Million
Previous $2.07 Million
18.58%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...